Paper35457101
Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.
Buglyó G and 7 others. Int J Mol Sci, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome. Papers, record 35457101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35457101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms, Hereditary Nonpolyposis | Major topic |
| Endometrial Neoplasms | Major topic |
| Nucleic Acids | Major topic |
| Biomarkers | |
| Biomarkers, Tumor | |
| DNA Mismatch Repair | |
| Female | |
| Germ-Line Mutation | |
| Humans | |
| Liquid Biopsy | |
| Microsatellite Instability |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| VEGA 1/0305/19 | Slovak Academy of Sciences | PubMed | ||
| ITMS: 313011V578 | European Regional Development Fund | PubMed |
Source PubMed
References145
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22262812 | Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. | Cancer Prev Res (Phila) | 2012 | https://conductscience.org/library/papers/22262812 | PubMed |
| 2 | 34489309 | Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment. | Gut | 2022 | https://conductscience.org/library/papers/34489309 | PubMed |
| 3 | 25345868 | Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome. | Clin Genet | 2015 | https://conductscience.org/library/papers/25345868 | PubMed |
| 4 | 9823339 | A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. | Cancer Res | 1998 | https://conductscience.org/library/papers/9823339 | PubMed |
| 5 | 33207777 | Technical and Methodological Aspects of Cell-Free Nucleic Acids Analyzes. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33207777 | PubMed |
| 6 | 28427387 | Serum MicroRNA profile in patients with colon adenomas or cancer. | BMC Med Genomics | 2017 | https://conductscience.org/library/papers/28427387 | PubMed |
| 7 | 26823726 | Combined identification of long non-coding RNA CCAT1 and HOTAIR in serum as an effective screening for colorectal carcinoma. | Int J Clin Exp Pathol | 2015 | https://conductscience.org/library/papers/26823726 | PubMed |
| 8 | 12621137 | Hereditary colorectal cancer. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12621137 | PubMed |
| 9 | 29120224 | Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer. | Arch Pathol Lab Med | 2018 | https://conductscience.org/library/papers/29120224 | PubMed |
| 10 | 32904278 | Genetic heterogeneity in a patient with Muir-Torre syndrome. | JAAD Case Rep | 2020 | https://conductscience.org/library/papers/32904278 | PubMed |
| 11 | 33290560 | NGS-based identification and tracing of microsatellite instability from minute amounts DNA using inter-Alu-PCR. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33290560 | PubMed |
| 12 | 25452455 | Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25452455 | PubMed |
| 13 | 18556776 | Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. | J Mol Diagn | 2008 | https://conductscience.org/library/papers/18556776 | PubMed |
| 14 | 20028993 | Risks of Lynch syndrome cancers for MSH6 mutation carriers. | J Natl Cancer Inst | 2010 | https://conductscience.org/library/papers/20028993 | PubMed |
| 15 | 27142899 | Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer. | Acta Cir Bras | 2016 | https://conductscience.org/library/papers/27142899 | PubMed |
| 16 | 29334918 | Colorectal cancer liver metastases - a population-based study on incidence, management and survival. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29334918 | PubMed |
| 17 | 26631156 | Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. | World J Surg Oncol | 2015 | https://conductscience.org/library/papers/26631156 | PubMed |
| 18 | 30631754 | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer. | Front Oncol | 2018 | https://conductscience.org/library/papers/30631754 | PubMed |
| 19 | 23957462 | Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer. | Aliment Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23957462 | PubMed |
| 20 | 34327297 | Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases. | JCO Precis Oncol | 2021 | https://conductscience.org/library/papers/34327297 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41987791 | A novel frameshift variant in MSH2 (p.Q170Rfs4) associated with suspected Lynch syndrome in a Chinese family. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41987791 | PubMed |
| 41594150 | Clinical Validation of DNA Methylation Detection in Cervical Exfoliated Cells for Endometrial Cancer in Women with Suspected Lesions. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41594150 | PubMed |
| 41228253 | Advances in Hereditary Colorectal Cancer: How Precision Medicine Is Changing the Game. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41228253 | PubMed |
| 40463737 | A Rare Case of Four Primary Tumors in a Patient With Lynch Syndrome. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/40463737 | PubMed |
| 38107069 | Hypermethylated CDO1 and CELF4 in cytological specimens as triage strategy biomarkers in endometrial malignant lesions. | Front Oncol | 2023 | https://conductscience.org/library/papers/38107069 | PubMed |
| 37802042 | Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy. | Am J Hum Genet | 2023 | https://conductscience.org/library/papers/37802042 | PubMed |
| 37542343 | Network approach in liquidomics landscape. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37542343 | PubMed |
| 37514090 | New Possible Ways to Use Exosomes in Diagnostics and Therapy via JAK/STAT Pathways. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37514090 | PubMed |
| 36980987 | Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/36980987 | PubMed |
| 36866160 | Microsatellite instability assessment is instrumental for Predictive, Preventive and Personalised Medicine: status quo and outlook. | EPMA J | 2023 | https://conductscience.org/library/papers/36866160 | PubMed |
| 35954375 | Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35954375 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35457101
GET https://conductscience.org/api/papers/v1/35457101/references?page=2